Sutton Wealth Advisors Inc. Haemonetics Corp Transaction History

Sutton Wealth Advisors Inc.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Nov 07, 2023	SELL	$72.75 - $90.6 $509 - $634	-7 Closed	0 $0
Q2 2022 Nov 07, 2023	SELL	$49.27 - $66.08 $394 - $528	-8 Reduced 53.33%	7 $456,000
Q1 2022 Nov 07, 2023	BUY	$43.77 - $63.22 $350 - $505	8 Added 114.29%	15 $948,000
Q4 2021 Nov 07, 2023	BUY	$49.55 - $74.59 $346 - $522	7 New	7 $371,000
Q4 2018 Nov 06, 2023	SELL	$90.66 - $116.63 $10,425 - $13,412	-115 Closed	0 $0
Q3 2018 Nov 06, 2023	SELL	$89.96 - $114.58 $2,249 - $2,864	-25 Reduced 17.86%	115 $13.2 Million
Q2 2018 Nov 06, 2023	SELL	$71.53 - $95.75 $48,711 - $65,205	-681 Reduced 82.95%	140 $12.6 Million
Q2 2016 Nov 06, 2023	SELL	N/A	-398 Reduced 32.65%	821 $23.8 Million
Q1 2016 Nov 06, 2023	BUY	N/A	1,219	1,219 $42.6 Million

337

54.3M

689K

345K

Ticker HAE
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 51,316,500
Market Cap $3.05B
Description
Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...

Get notified when there are updates to the investment portfolio of Sutton Wealth Advisors Inc., based on Form 13F filings with the SEC.

Stay updated on Sutton Wealth Advisors Inc. with notifications on news.